go.cega.org/cashimpacts
A 🧵
go.cega.org/cashimpacts
A 🧵
Brilliant. No notes!
Brilliant. No notes!
Here’s a quick look at what to expect:
Sam Power quoted in this fab story from Devex's @elissamio.bsky.social that pulls you right in.
www.devex.com/news/samanth...
Sam Power quoted in this fab story from Devex's @elissamio.bsky.social that pulls you right in.
www.devex.com/news/samanth...
Executive Director @carsonchristiano.bsky.social calls for investing in research to maximize impact with limited resources, especially in cost-effectiveness initiatives like CEGA's PILCEE program. #econsky
cega.berkeley.edu/article/evid...
Executive Director @carsonchristiano.bsky.social calls for investing in research to maximize impact with limited resources, especially in cost-effectiveness initiatives like CEGA's PILCEE program. #econsky
cega.berkeley.edu/article/evid...
Amazing energy in defense of science, and it felt good to do something positive, even if it's just a small step.
Below is the text I read. #StandUpForScience !
🧪
@standupforscience.bsky.social
#standupforscience2025
🧪
@standupforscience.bsky.social
#standupforscience2025
apnews.com/article/scie...
apnews.com/article/scie...
I don’t remember seeing anything like this before
I don’t remember seeing anything like this before
This would be good comedy if it didn't matter so much www.propublica.org/article/ted-...
This would be good comedy if it didn't matter so much www.propublica.org/article/ted-...
We generate rigorous research on global poverty, using innovative data, methods, and partnerships, to improve the lives of millions.
We also provide policymakers & funders cost-effective strategies to scale evidence-backed solutions for development.
www.youtube.com/watch?v=_fps...
We generate rigorous research on global poverty, using innovative data, methods, and partnerships, to improve the lives of millions.
We also provide policymakers & funders cost-effective strategies to scale evidence-backed solutions for development.
www.youtube.com/watch?v=_fps...
The recent slashing of NIH indirect cost rates is unlikely to survive. It’s another Trump stunt.
Courts will have a say. And so will OMB.
And pharmaceutical companies won’t stand for it. NIH-backed research enjoys a ton of congressional (and lobbyist) support.
The recent slashing of NIH indirect cost rates is unlikely to survive. It’s another Trump stunt.
Courts will have a say. And so will OMB.
And pharmaceutical companies won’t stand for it. NIH-backed research enjoys a ton of congressional (and lobbyist) support.